{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:02:43Z","timestamp":1761418963469},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T00:00:00Z","timestamp":1421798400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0751-0","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T17:16:56Z","timestamp":1421774216000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Human leukocyte antigen class I and class II alleles are associated with susceptibility and resistance in borderline leprosy patients from Southeast Brazil"],"prefix":"10.1186","volume":"15","author":[{"given":"Fabiana Covolo","family":"de Souza-Santana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine Valim Camarinha","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Esther Salles","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somei","family":"Ura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Tomimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,21]]},"reference":[{"key":"751_CR1","first-page":"49","volume-title":"Leprosy","author":"RJW Rees","year":"1994","unstructured":"Rees RJW. The microbiology of leprosy. In: Hastings RC, editor. Leprosy. 4th ed. Edinburg: Churchil Livingstone; 1994. p. 49\u201383.","edition":"4"},{"key":"751_CR2","first-page":"255","volume":"34","author":"DS Ridley","year":"1966","unstructured":"Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34:255\u201373.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"751_CR3","volume-title":"Formas cl\u00ednicas de la lepra","author":"DVA Opromolla","year":"1978","unstructured":"Opromolla DVA, Fleury RN. Formas cl\u00ednicas de la lepra. Cidade do M\u00e9xico: Anais Congresso Internacional de la Lepra; 1978."},{"key":"751_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.47878\/hi.1981.v6.35610","volume":"6","author":"AC Pereira J\u00fanior","year":"1981","unstructured":"Pereira J\u00fanior AC, Gurfinkel AC. Positioning of borderline and indetermined groups in the hanseniasis classification. Hansen Int. 1981;6:63\u201370.","journal-title":"Hansen Int."},{"key":"751_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","volume":"19","author":"DM Scollard","year":"2006","unstructured":"Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338\u201381.","journal-title":"Clin Microbiol Rev."},{"key":"751_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1489\/1544-581X(2004)072<0125:ECOLRY>2.0.CO;2","volume":"72","author":"B Kumar","year":"2004","unstructured":"Kumar B, Dogra S, Kaur I. Epidemiological characteristics of leprosy reactions: 15\u00a0years experience from north India. Int J Lepr Other Mycobact Dis. 2004;72:125\u201333.","journal-title":"Int J Lepr Other Mycobact Dis."},{"key":"751_CR7","first-page":"51","volume-title":"No\u00e7\u00f5es de Hansenologia","author":"DVA Opromolla","year":"2000","unstructured":"Opromolla DVA. Manifesta\u00e7\u00f5es Cl\u00ednicas e Rea\u00e7\u00f5es. In: Opromolla DVA, editor. No\u00e7\u00f5es de Hansenologia. 2nd ed. Bras\u00edlia: Centro de Estudos Dr. Reynaldo Quagliato; 2000. p. 51\u20138.","edition":"2"},{"key":"751_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tube.2004.09.011","volume":"85","author":"THM Ottenhoff","year":"2005","unstructured":"Ottenhoff THM, Verreck FAW, Hoeve MA, van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis. 2005;85:53\u201364.","journal-title":"Tuberculosis."},{"key":"751_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.gene.6363926","volume":"3","author":"J Fitness","year":"2002","unstructured":"Fitness J, Tosh K, Hill AVS. Genetics of susceptibility to leprosy. Genes Immun. 2002;3:441\u201353.","journal-title":"Genes Immun."},{"key":"751_CR10","first-page":"199","volume":"51","author":"ML Petzel-Erler","year":"1999","unstructured":"Petzel-Erler ML. Genetics of the immune response and disease susceptibility. Cienc Cult. 1999;51:199\u2013211.","journal-title":"Cienc Cult."},{"key":"751_CR11","volume-title":"Cellular and molecular immunology","author":"AK Abbas","year":"2010","unstructured":"Abbas AK, Linchtman AHL, Pillai S. Cellular and molecular immunology. 6th ed. Philadelphia: Sauders Elsevier; 2010.","edition":"6"},{"key":"751_CR12","first-page":"11","volume":"10","author":"P Lagrange","year":"1996","unstructured":"Lagrange P, Abel L. Susceptibilit\u00e9 g\u00e9n\u00e9tique \u00e0 la l\u00e8pre chez l\u2019homme. Acta Leprol. 1996;10:11\u201327.","journal-title":"Acta Leprol."},{"key":"751_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1399-0039.1978.tb01225.x","volume":"11","author":"H Takata","year":"1978","unstructured":"Takata H, Sada M, Ozawa S, Sekiguchi S. HLA and mycobacterial infection: increased frequency of B8 in Japanese leprosy. Tissue Antigens. 1978;11:61\u20134.","journal-title":"Tissue Antigens."},{"key":"751_CR14","first-page":"3","volume":"12","author":"SH Chan","year":"1983","unstructured":"Chan SH. HLA and skin disease in the Chinese. Ann Acad Med Singapore. 1983;12:3\u20135.","journal-title":"Ann Acad Med Singapore."},{"key":"751_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1155\/S1110724303210019","volume":"2003","author":"U Shankarkumar","year":"2003","unstructured":"Shankarkumar U, Ghosh K, Badakere S, Mohanty D. Novel HLA Class I Alleles Associated with Indian Leprosy Patients. J Biomed Biotechnol. 2003;2003:208\u201311.","journal-title":"J Biomed Biotechnol."},{"key":"751_CR16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.47276\/lr.75.1.79","volume":"75","author":"U Shankarkumar","year":"2004","unstructured":"Shankarkumar U. HLA associations in leprosy patients from Mumbai, India. Lepr Rev. 2004;75:79\u201385.","journal-title":"Lepr Rev."},{"key":"751_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1590\/S0037-86822011000500018","volume":"44","author":"DSA Franceschi","year":"2011","unstructured":"Franceschi DSA, Tsuneto LT, Mazini PS, Sacramento WS, Reis PG, Rudnick CCC, et al. Class-I human leukocyte alleles in leprosy patients from Southern Brazil. Rev Soc Bras Med Trop. 2011;44:616\u201320.","journal-title":"Rev Soc Bras Med Trop."},{"key":"751_CR18","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/infdis\/jir024","volume":"203","author":"A Alter","year":"2011","unstructured":"Alter A, Huong NT, Singh M, Orlova M, Van Thuc N, Katoch K, et al. Human leukocyte antigen class I region single-nucleotide polymorphisms are associated with leprosy susceptibility in Vietnam and India. J Infect Dis. 2011;203:1274\u201381.","journal-title":"J Infect Dis."},{"key":"751_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/infdis\/141.6.693","volume":"141","author":"W Eden Van","year":"1980","unstructured":"Van Eden W, de Vries RR, Mehra NK, Vaidya MC, D\u2019Amaro J, van Rood JJ. HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker. J Infect Dis. 1980;141:693\u2013701.","journal-title":"J Infect Dis."},{"key":"751_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1399-0039.1980.tb00309.x","volume":"16","author":"RR Vries De","year":"1980","unstructured":"De Vries RR, Mehra NK, Vaidya MC, Gupte MD, Meera Khan P, Van Rood JJ. HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types. Tissue Antigens. 1980;16:294\u2013304.","journal-title":"Tissue Antigens."},{"key":"751_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1399-0039.1981.tb01381.x","volume":"18","author":"W Eden Van","year":"1981","unstructured":"Van Eden W, Mehra NK, Vaidya MC, D\u2019Amaro J, Schreuder GM, van Rood JJ. HLA and sporadic tuberculoid leprosy: a population study in Maharashtra, India. Tissue Antigens. 1981;18:189\u201394.","journal-title":"Tissue Antigens."},{"key":"751_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0198-8859(82)90007-6","volume":"4","author":"W Eden Van","year":"1982","unstructured":"Van Eden W, de Vries RR, D\u2019Amaro J, Schreuder I, Leiker DL, van Rood JJ. HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol. 1982;4:343\u201350.","journal-title":"Hum Immunol."},{"key":"751_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/S0100-879X1997000100008","volume":"30","author":"JE Visentainer","year":"1997","unstructured":"Visentainer JE, Tsuneto LT, Serra MF, Peixoto PR, Petzl-Erler ML. Association of leprosy with HLA-DR2 in a Southern Brazilian population. Braz J Med Biol Res. 1997;30:51\u20139.","journal-title":"Braz J Med Biol Res."},{"key":"751_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1399-0039.1993.tb02179.x","volume":"42","author":"R Rani","year":"1993","unstructured":"Rani R, Fernandez-Vina MA, Zaheer SA, Beena KR, Stastny P. Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens. 1993;42:133\u20137.","journal-title":"Tissue Antigens."},{"key":"751_CR25","first-page":"178","volume":"65","author":"PR Klatser","year":"1997","unstructured":"Klatser PR, Janson AM, Thole JE, Buhrer S, Bos C, Soebono H, et al. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Int J Lepr Other Mycobact Dis. 1997;65:178\u201389.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"751_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tube.2003.08.009","volume":"84","author":"C Gorodezky","year":"2004","unstructured":"Gorodezky C, Alaez C, Mungu\u00eda A, Cruz R, Vazquez A, Camacho A, et al. Molecular mechanisms of MHC linked susceptibility in leprosy: towards the development of synthetic vaccines. Tuberculosis. 2004;84:82\u201392.","journal-title":"Tuberculosis."},{"key":"751_CR27","first-page":"282","volume":"75","author":"EVC Marcos","year":"2000","unstructured":"Marcos EVC, de Souza FC, Ura S, Opromolla DVA. Study of the association of HLA antigens and ulcerated type 1 leprotic reaction. An Bras Dermatol. 2000;75:282\u201390.","journal-title":"An Bras Dermatol."},{"key":"751_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1399-0039.1987.tb01567.x","volume":"29","author":"SJ Kim","year":"1987","unstructured":"Kim SJ, Choi IH, Dahlberg S, Nisperos B, Kim JD, Hansen JA. HLA and leprosy in Koreans. Tissue Antigens. 1987;29:146\u201353.","journal-title":"Tissue Antigens."},{"key":"751_CR29","first-page":"49","volume":"68","author":"S Joko","year":"2000","unstructured":"Joko S, Numaga J, Kawashima H, Namisato M, Maeda H. Human leukocyte antigens in forms of leprosy among Japanese patients. Int J Lepr Other Mycobact Dis. 2000;68:49\u201356.","journal-title":"Int J Lepr Other Mycobact Dis."},{"key":"751_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1046\/j.1365-4362.2002.01602.x","volume":"41","author":"AA Hegazy","year":"2002","unstructured":"Hegazy AA, Abdel-Hamid IA, Ahmed E-SF, Hammad SM, Hawas SA. Leprosy in a high-prevalence Egyptian village: epidemiology and risk factors. Int J Dermatol. 2002;41:681\u20136.","journal-title":"Int J Dermatol."},{"key":"751_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/sj.gene.6364390","volume":"8","author":"PR Vanderborght","year":"2007","unstructured":"Vanderborght PR, Pacheco AG, Moraes ME, Antoni G, Romero M, Verville A, et al. HLA-DRB1*04 and DRB1*10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients. Genes Immun. 2007;8:320\u20134.","journal-title":"Genes Immun."},{"key":"751_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2334-9-134","volume":"9","author":"SA Silva Da","year":"2009","unstructured":"Da Silva SA, Mazini PS, Reis PG, Sell AM, Tsuneto LT, Peixoto PR, et al. HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistance. BMC Infect Dis. 2009;9:134.","journal-title":"BMC Infect Dis."},{"key":"751_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1471-2350-10-133","volume":"10","author":"F Zhang","year":"2009","unstructured":"Zhang F, Liu H, Chen S, Wang C, Zhu C, Zhang L, et al. Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population. BMC Med Genet. 2009;10:133.","journal-title":"BMC Med Genet."},{"key":"751_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5025\/hansen.65.121","volume":"65","author":"S Joko","year":"1996","unstructured":"Joko S, Numaga J, Masuda K, Namisato M, Maeda H. HLA class II alleles and leprosy (Hansen\u2019s disease) classified by WHO-MDT criteria. Nihon Rai Gakkai Zasshi. 1996;65:121\u20137.","journal-title":"Nihon Rai Gakkai Zasshi."},{"key":"751_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.gene.6364031","volume":"5","author":"EN Miller","year":"2004","unstructured":"Miller EN, Jamieson SE, Joberty C, Fakiola M, Hudson D, Peacock CS, et al. Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes Immun. 2004;5:63\u20137.","journal-title":"Genes Immun."},{"key":"751_CR36","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1056\/NEJMoa0903753","volume":"361","author":"F-R Zhang","year":"2009","unstructured":"Zhang F-R, Huang W, Chen S-M, Sun L-D, Liu H, Li Y, et al. Genomewide association study of leprosy. N Engl J Med. 2009;361:2609\u201318.","journal-title":"N Engl J Med."},{"key":"751_CR37","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.","journal-title":"Nucleic Acids Res."},{"key":"751_CR38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/117693430500100003","volume":"1","author":"L Excoffier","year":"2005","unstructured":"Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online. 2005;1:47\u201350.","journal-title":"Evol Bioinform Online."},{"key":"751_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1128\/CMR.00048-08","volume":"22","author":"JM Blackwell","year":"2009","unstructured":"Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev. 2009;22:370\u201385.","journal-title":"Clin Microbiol Rev."},{"key":"751_CR40","first-page":"401","volume":"58","author":"C Gorodezky","year":"1987","unstructured":"Gorodezky C, Flores J, Arevalo N, Castro LE, Silva A, Rodriguez O. Tuberculoid leprosy in Mexicans is associated with HLA-DR3. Lepr Rev. 1987;58:401\u20136.","journal-title":"Lepr Rev."},{"key":"751_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1365-2230.2002.01004.x","volume":"27","author":"M Ko\u00e7ak","year":"2002","unstructured":"Ko\u00e7ak M, Balci M, Pen\u00e7e B, Kundak\u00e7i N. Associations between human leukocyte antigens and leprosy in the Turkish population. Clin Exp Dermatol. 2002;27:235\u20139.","journal-title":"Clin Exp Dermatol."},{"key":"751_CR42","doi-asserted-by":"publisher","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","volume":"39","author":"FF Gonzalez-Galarza","year":"2011","unstructured":"Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011;39:D913\u20139.","journal-title":"Nucleic Acids Res."},{"key":"751_CR43","unstructured":"Romero M. Estudo de Associa\u00e7\u00e3o entre o Sistema HLA e a Hansen\u00edase. MsD thesis. Instituto Oswaldo Cruz; 2010. p. 101"},{"key":"751_CR44","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1157\/13112938","volume":"25","author":"PMF Motta","year":"2007","unstructured":"Motta PMF, Cech N, Fontan C, Gim\u00e9nez MF, Lodeiro N, Marinic K, et al. Role of HLA-DR and HLA-DQ alleles in multibacillary leprosy and paucibacillary leprosy in the province of Chaco (Argentina). Enferm Infecc Microbiol Clin. 2007;25:627\u201331.","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"751_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/infdis\/151.1.9","volume":"151","author":"W Eden Van","year":"1985","unstructured":"Van Eden W, Gonzalez NM, de Vries RR, Convit J, van Rood JJ. HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis. 1985;151:9\u201314.","journal-title":"J Infect Dis."},{"key":"751_CR46","first-page":"261","volume":"55","author":"TM Ottenhoff","year":"1987","unstructured":"Ottenhoff TM, Converse G, De Vries R. HLA Antigens and Neural Reversal Reaction in Ethiopian Boderline Tuberculoid Leprosy Patients. Int JLeprosy. 1987;55:261\u20136.","journal-title":"Int JLeprosy."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0751-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0751-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0751-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0751-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:46:08Z","timestamp":1717695968000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0751-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,21]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0751-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,21]]},"assertion":[{"value":"17 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}